What is THCV (Tetrahydrocannabivarin)?

THCV (Tetrahydrocannabivarin) is a minor cannabinoid found in cannabis that shares structural similarities with THC but exhibits distinct pharmacological properties. Unlike THC, THCV typically produces no psychoactive effects at low doses and may actually counteract some of THC's intoxicating properties, earning it the nickname "diet weed." THCV is primarily found in sativa strains originating from Africa, particularly landrace varieties from regions like South Africa, Nigeria, and Ghana. Concentrations typically range from 0.2% to 1.8% in most cannabis varieties, though some African sativas can contain up to 4% THCV. Popular strains known for higher THCV content include Durban Poison, Red Congolese, and Doug's Varin. The cannabinoid exhibits a biphasic dose-response relationship. At lower doses (under 10mg), THCV acts as a CB1 receptor antagonist, potentially suppressing appetite and reducing anxiety. At higher doses, it may activate CB1 receptors and produce mild psychoactive effects, though research remains limited. THCV has garnered significant interest from researchers and the cannabis industry for its potential therapeutic applications. Preliminary studies suggest it may help regulate blood sugar levels, reduce appetite, and possess anti-inflammatory properties. However, clinical research is still in early stages, and no medical claims have been FDA-approved. The commercial market for THCV products has expanded rapidly since 2020, with specialized extracts, tinctures, and isolates becoming available in legal markets. Market analysis indicates THCV products command premium pricing, often 2-3 times higher than standard THC products due to extraction complexity and limited source material. **Disclaimer:** This information is for educational purposes only and should not be considered medical advice. Consult healthcare professionals before using cannabis products for therapeutic purposes.